A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Clinical trial NCT02871570 · COMPLETED

Trial details

NCT number: NCT02871570
Sponsor: GlycoMimetics Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Hepatic Impairment Normal Hepatic Function

Start date: 2016-09-01
Primary completion: 2017-02-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.